Bid Price | 32.00p | High Price | 35.00p |
---|
Ask Price | 35.00p | Low Price | 32.00p |
---|
Open Price | 34.00p | Spread | 8.57% |
---|
Prev Close | 34.00p | Volume | 15,325 |
---|
Tissue Regenix Group PLC Historic Prices
Date | Open | High | Low | Close | Volume |
---|
Aug 1, 2025 | 35.00 | 35.00 | 33.00 | 34.00 | 27,158 |
Jul 31, 2025 | 36.50 | 36.70 | 34.25 | 35.50 | 42,838 |
Jul 30, 2025 | 37.00 | 37.00 | 35.00 | 36.50 | 15,120 |
Jul 29, 2025 | 37.00 | 37.90 | 36.00 | 37.00 | 311 |
Jul 28, 2025 | 38.00 | 39.80 | 35.00 | 37.00 | 36,092 |
More Tissue Regenix Group PLC Historic Prices >Tissue Regenix Group PLC Information
Name | Tissue Regenix Group PLC | Index | FTSE AIM All Share |
---|
ISIN | GB00BNTXR104 | Epic | TRX |
---|
Type | Equity | Currency | GBX |
---|
Record Status | Active | Trading Segment | ASQ1 |
---|
Industry | Biotechnology | Sector | Healthcare |
---|
EMS | 2,000 | Trading Status | Post Trading |
---|
Shares in Issue | 71.23 m | Prev Close | 34.00p |
---|
PE Ratio | | Market Cap | £24.93 m |
---|
Div Yield | 0 | Div per Share | $NaN |
---|
EPS | -$0.01 | Div Cover | NaN |
---|
PEG | n/a | EPS Growth (%) | 0.00 |
---|
ROCE | 7.76E-4 | DPS Growth (%) | 0 |
---|
Current Ratio | 3.455727 | Quick Ratio | 1.015435 |
---|
Tissue Regenix Group PLC Director Deals
Declared | Type | Director | Pos. | Volume / Price | Value |
---|
27/06/24 | EXR | Daniel Lee | CEO | 283,216 @ £0.10 | £28,322.00 |
27/06/24 | SEXR | Daniel Lee | CEO | 87,611 @ £0.61 | £53,443.00 |
27/06/24 | SEXR | David Cocke | FD | 63,207 @ £0.61 | £38,556.00 |
27/06/24 | EXR | David Cocke | FD | 146,491 @ £0.10 | £14,649.00 |
15/09/23 | BUY | George Phillips | NED | 6,773 @ £0.54 | £3,657.00 |
05/04/23 | BUY | Daniel Lee | CEO | 500,000 @ £0.01 | £2,850.00 |
05/04/23 | BUY | Daniel Lee | CEO | 928,570 @ £0.01 | £5,246.00 |
05/04/23 | BUY | David Cocke | FD | 928,570 @ £0.01 | £5,246.00 |
05/04/23 | BUY | David Cocke | FD | 500,000 @ £0.01 | £2,850.00 |
29/09/22 | BUY | Daniel Lee | CEO | 2,000,000 @ £0.00 | £9,700.00 |
More Tissue Regenix Group PLC Director Deals >Tissue Regenix Group PLC News